CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,043,610
- in 4 filings, $16.0M under 10b5-1 plans
Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-23 | ZDRAVESKI ZORAN See Remarks | Sale | −4,181 | $16.03 | $67K | 140,092 |
| 2019-12-23 | ZDRAVESKI ZORAN See Remarks | Option exercise · Stock Option (Right to Buy) | −4,172 | 129,342 | ||
| 2019-12-23 | ZDRAVESKI ZORAN See Remarks | Option exercise · Stock Option (Right to Buy) | −9 | 17,676 | ||
| 2019-12-23 | ZDRAVESKI ZORAN See Remarks | Sale | −4,181 | $16.03 | $67K | 135,911 |
| 2019-12-23 | ISACSON CHRISTINA K. Chief Business Officer | Sale | −9,867 | $16.03 | $158K | 88,249 |
| 2019-12-23 | GARDNER JASON See Remarks | Sale | −2,897 | $15.10 | $44K | 265,212 |
| 2019-12-20 | GARDNER JASON See Remarks | Sale | −76,711 | $15.16 | $1.2M | 268,109 |
| 2019-12-20 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise | +114 | $9.49 | $1K | 8,418 |
| 2019-12-20 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise | +805 | $9.49 | $8K | 9,223 |
| 2019-12-20 | DAVIS JOHN C. JR Chief Medical Officer | Sale | −919 | $15.00 | $14K | 8,304 |
| 2019-12-20 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −805 | 236,239 | ||
| 2019-12-20 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −114 | 236,125 | ||
| 2019-12-10 | GARDNER JASON See Remarks | Sale | −4,392 | $15.10 | $66K | 344,820 |
| 2019-12-10 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise | +17,055 | $9.49 | $162K | 25,359 |
| 2019-12-10 | DAVIS JOHN C. JR Chief Medical Officer | Sale | −17,055 | $15.00 | $256K | 8,304 |
| 2019-12-10 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −17,055 | 237,044 | ||
| 2019-12-09 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise | +4,614 | $9.49 | $44K | 12,918 |
| 2019-12-09 | DAVIS JOHN C. JR Chief Medical Officer | Sale | −4,614 | $15.00 | $69K | 8,304 |
| 2019-12-09 | DAVIS JOHN C. JR Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,614 | 254,099 | ||
| 2019-12-02 | COOKE MICHAEL P. Chief Scientific Officer | Sale | −3,627 | $12.74 | $46K | 244,396 |
Page 19 of 24 · 470 trades